Multiple studies have highlighted modifications in amino acid metabolism, mitochondrial function, oxidative stress, and energy metabolism following dietary intervention, dysregulation of which is implicated in ASD [16, 17]
The impact and detailed mechanisms of organokines-mediated interactions warrant further investigation under both physiological and pathological conditions
Nearly 40% of trial participants on sibutramine experienced these side effects, while only 9% of those taking tesofensine experienced them
Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism
The caution here isnt about the drug itself its about the gray market already forming around it
Unlike traditional GLP-1 escalation protocols